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The two major glycosphingolipids of myelin, galactosylceramide (GalC) and sulfatide (SGC), interact
with each other by trans carbohydrate–carbohydrate interactions. They face each other in the
apposed extracellular surfaces of the multilayered myelin sheath produced by oligodendrocytes
(OLs). Multivalent galactose and sulfated galactose, in the form of GalC/SGC-containing liposomes
or silica nanoparticles conjugated to galactose and galactose-3-sulfate, interact with GalC and SGC
in the membrane sheets of OLs in culture. This stimulus results in transmembrane signaling, loss
of the cytoskeleton and clustering of membrane domains, suggesting that GalC and SGC could par-
ticipate in glycosynapses between apposed OL membranes or extracellular surfaces of mature mye-
lin. Such glycosynapses may be important for myelination and/or myelin function.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction Despite their abundance, these GSLs are not essential for OLMyelin is the membranous sheath that is spirally wound around
nerve axons (Fig. 1C) and is formed in the central nervous system
by oligodendrocytes (OLs). The myelin membrane is rich in two
glycosphingolipids (GSLs), galactosylceramide (GalC) and sulfatide
(the sulfated form of GalC, galactosylceramide I3-sulfate (SGC)).
The extracellular surfaces of myelin, which face each other in the
multilayered myelin sheath, would thus be covered with the sim-
ple sugars, galactose and sulfated galactose [1].chemical Societies. Published by E
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out the genes encoding the enzymes that are necessary for their
synthesis, UDP-galactose:ceramide galactosyltransferase (CGT)
and galactosylceramide 30-sulfotransferase (CST), does not prevent
formation of compact myelin sheaths, which appear only slightly
thinner than normal but with altered interaction of paranodal
loops with the axon [2–4]. Delocalization of axolemmal proteins
occurs around the node and paranode in these mutants, which
may be partly due to altered trafﬁcking of myelin paranodal pro-
teins to the plasma membrane [2]. However, the CGT-null mice
display a severe clinical phenotype, with nerve conduction deﬁcits,
paralysis, extensive myelin vacuolation and splitting at the intra-
period line, and early death [2]. The phenotype is much less severe
in the CST knockouts, but with age, the nodal structure deterio-
rates, the amount of cytoplasm in myelin increases, and myelin
vacuolar degeneration occurs [3]. Terminal differentiation of OLs
from the CST knockouts is enhanced in vitro and in vivo, suggesting
that SGC is a negative regulator of OL differentiation [4–6]. The
number of terminally differentiated OLs is increased in vivo and
this increase persists into adulthood in CST-null mice, due to in-
creased proliferation and decreased apoptosis [7].
The myelin produced in the CGT mutant contains the hydroxy-
fatty acid form of glucosylceramide (HFA-GluC) (normally absent
in OLs) instead of GalC and SGC and also increased ceramide levels.lsevier B.V. All rights reserved.
Fig. 1. Sites where glycosynapses between GalC/Sulf-enriched domains in OL/
myelin membranes might occur resulting in signaling and depolymerization of the
cytoskeleton. A double headed pink arrow represents glycosynapse formation
between two OL membranes (panels A and B), or a series of glycosynapses between
the multilayers of the myelin sheath (panel C). (A) Glycosynapse between two
different OLs – could be a signal for process retraction or cessation of growth of a
membrane sheet. (B) Glycosynapse between extracellular surfaces of membranes of
a process of the same cell wrapping around an axon (orange, labeled A) – could be a
signal for elimination of cytosol and formation of closely packed (compact) myelin
layers. (C) Series of glycosynapses between the extracellular surfaces (at intraperiod
line shown in light green) of compact myelin surrounding a nerve axon – could
transmit extracellular or axonal signals throughout myelin layers. Major dense line
where cytosolic surfaces are apposed is shown in darker green. The outer loop and
inner loop containing cytoplasm are shown in green. Reprinted from Boggs et al. [1]
with permission from Elsevier.
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UDP-glucose:ceramide glucosyltransferase, targeted to OLs in the
CGT mutant, has no signiﬁcant effect on the phenotype, indicating
that the HFA-GluC does not compensate for the loss of GalC and
SGC [8]. These results suggest that galactolipids are necessary for
development of a normal myelin sheath that can sustain the axon
and for maintenance of compact myelin structure with age,
although they are not necessary for the process of myelination.
Galactosphingolipids may perform their role in myelin function
through several possible mechanisms, i.e., their ordering effect on
the lipid bilayer, their formation of rafts, and/or binding to speciﬁc
ligands which trigger signaling. Galactosphingolipids have longer,
more saturated fatty acids than phospholipids, and can also partic-
ipate in an intermolecular hydrogen bonding network [9], whichcauses them to form more ordered membrane domains or rafts
that are involved in protein trafﬁcking [13] and/or organization
of speciﬁc proteins into signaling complexes. GalC is concentrated
with cholesterol, GM1, the raft marker ﬂotillin, caveolin, glycosyl-
phosphatidylinositol (GPI)-linked proteins and kinases [10–15] in
low density detergent-insoluble glycosphingolipid-enriched mem-
brane domains (DIGs) believed to come from membrane domains
or rafts in OL and myelin membranes. These DIGs also contain
SGC but are not enriched in it [11]. They also contain some myelin
proteins including myelin basic protein (MBP), a peripheral mem-
brane protein bound to the cytoplasmic side of the membrane, and
phosphorylated MBP [12]. The GalC and SGC in these membrane
domains can receive extracellular signals that are then transmitted
to the cytosol.2. Involvement of myelin GSLs in signaling
Anti-GalC and anti-SGC antibodies (Abs) have diverse effects on
cultured mouse OLs and Schwann cells suggesting that they can
activate GSL-enriched signaling domains in these cells. The extra-
cellular signals imparted by the Abs are transmitted across the
membrane to the cytoplasmic side and to the cytoskeleton (re-
viewed in [16,17]) and affect OL differentiation [5,6,18]. Anti-GalC
and anti-SGC Abs caused redistribution of GalC and SGC over do-
mains containing MBP in OLs, and depolymerization of a lacy net-
work of microtubules in the membrane sheets [16,17]. Anti-GalC
Ab caused an inﬂux of extracellular Ca2+, rapid cycling of the
phospholipid polar head groups, and a decrease in phosphoryla-
tion of MBP [16,17,19]. Signiﬁcantly, it did not have these effects
on cultured OLs from the shiverer mutant mouse, which lacks
MBP, indicating that MBP is required to mediate the effects of
anti-GalC Ab on OLs [19]. Anti-SGC Ab inhibited differentiation
of progenitor OLs [5,6] and down-regulated gene expression in
mature OLs [18] consistent with the accelerated developmental
time course of cultured OLs from the CGT and CST mutants, sug-
gesting that SGC is involved in signaling mechanisms that regulate
differentiation [4,5,7].
3. Transmission of transmembrane signals by GalC/SGC
interactions across apposed membranes
The effects of anti-GalC and anti-SGC Abs on cultured OLs sug-
gest that there may be natural ligands that interact with these GSLs
in signaling domains to confer signals that are transmitted across
the membrane. These ligands may include axonal, OL, or extracel-
lular matrix proteins, but may also be glycolipids in apposed mem-
branes. Glycoconjugates, including glycolipids, can adhere to each
other by homotypic or heterotypic trans carbohydrate–carbohy-
drate interactions between apposed membranes [20]. The interac-
tions between these GSLs in GSL-enriched microdomains in
apposed membranes trigger signals, perhaps as a result of non-
covalent crosslinking or patching of the GSLs by the multivalent ar-
ray of sugars, similar to the effect of Abs crosslinked by anti-Ig Abs.
These signals are transmitted across the membrane to cytosolic
signal transduction proteins [21,22]. Hakomori has described
GSL-enriched signaling domains interacting with each other across
apposed cell membranes as a type of ‘‘glycosynapse”, similar to the
immunological synapse [23].
Like several other GSLs, the myelin GSLs, GalC and SGC, can also
participate in trans carbohydrate–carbohydrate interactions be-
tween apposed membranes [20,24]. We have suggested that they
may be ligands for each other and that trans interactions between
them may cause similar signaling effects as the Abs [1,25]. We
have tested this hypothesis by adding phospholipid/cholesterol
liposomes containing GalC/SGC, or a polyvalent form of galactose
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[25–27]. These systems would mimic an interaction which might
occur between GalC and SGC in apposed membranes, such as be-
tween the facing pairs of extracellular surfaces of myelin, or be-
tween OLs or their processes in contact with each other (Fig. 1).
The GalC/SGC-containing liposomes caused redistribution of
GalC on the extracellular side, and MBP on the cytosolic side, into
clusters of varying size such that the GalC domains usually overlaid
the MBP domains [27]. Similar clustering of GPI-linked proteins
and of two transmembrane proteins, proteolipid protein (PLP)
and myelin/oligodendrocyte glycoprotein (MOG), occurred, sug-
gesting that the domains which cluster are membrane rafts
[1,25,26]. Several proteins or phosphorylated proteins involved in
signal transduction, mitogen activated protein kinase (MAPK),
phosphorylated MBP, and some phospho-tyrosine-containing pro-
teins also clustered with MBP and GalC [26], suggesting that these
rafts are membrane signaling domains. Indeed, the GalC/SGC-con-
taining liposomes also caused depolymerization of microtubules
and actin ﬁlaments that form a lacy cytoskeletal network in the
membrane sheets, indicating that the interaction of GalC/SGC-con-
taining liposomes with the extracellular surface of the OL caused
transmission of a signal across the membrane. Inhibition of a num-
ber of kinases and phosphatases involved in regulation of the cyto-
skeleton with various reagents prevented the liposome-mediated
effects on the cytoskeleton [1,28].
However, liposomes can affect cells either by adhering to them
or by exchange of lipids between the liposomes and the cells. In
support of the former mechanism, control liposomes without GalC
or SGC had much less effect on GalC redistribution than those con-
taining GalC and SGC. Liposomes containing only one myelin GSL,
either SGC or GalC, had a signiﬁcantly greater effect than those
lacking GalC and SGC [26]. Furthermore, Gal-BSA had a similar ef-
fect as the GalC-containing liposomes [26]. Similar glycoconjugates
of glucose and mannose had signiﬁcantly less effect.4. Effect of multivalent glyco-nanoparticles on OLs
Dendrimers or silica nanoparticles conjugated with saccharides
are other forms of multivalent presentations which have been
used to mimic trans interactions between cell surface glycans.
Azide-functionalized silica nanoparticles can be conjugated with
propargyl derivatives of sugars by copper-promoted azide-alkyne
cycloaddition. We have examined the effect of silica nanoparti-
cles bearing galactose (Gal-nanoparticles), galactose-3-sulfate
(SGal-nanoparticles), or a combination of galactose and galact-
ose-3-sulfate (Gal/SGal-nanoparticles) on OLs. Propargyl b-D-3-sul-
fogalactose was synthesized by regioselective sulfonation of the
dibutylstannylene ketal prepared from propargyl b-D-galactose
[29]. Silica nanoparticles were functionalized with Gal (1.3 lmol
galactose/mg nanoparticles, corresponding to complete coverage),
SGal (0.8 lmol/mg) and a mixture of Gal/SGal (0.6 lmol Gal +
0.5 lmol SGal/mg) (J. Zhao and A. Basu, unpublished). (Details for
nanoparticle preparation and characterization will be provided
upon request.) The SGal nanoparticles were capped with propargyl
alcohol (0.4 lmol/mg particles) to block unreacted azido groups.
Control glyco-nanoparticles contained 1.3 lmol glucose (Glu-
nanoparticles) or mannose/mg particles (Man-nanoparticles).
Unglycosylated control particles were capped with propargyl alco-
hol to provide a hydroxyl-terminated nanoparticle. The nanoparti-
cles were incubated with OLs at a ﬁnal concentration of 2 lg/ml for
6–18 h.
The glyco-nanoparticles had a greater effect on the OLs than
GalC/SGC-containing liposomes or Gal-BSA, with some effect seen
after 6 h and a greater effect after overnight culture. In contrast,
culture with the cells overnight was required to detect effectsof the liposomes or Gal-BSA. Similar to liposomes and Gal-BSA,
the glyco-nanoparticles also caused clustering/redistribution of
GalC and MBP in the OL membrane sheets (shown for Gal-nano-
particles in panels d–f of Fig. 2, compare to untreated cells in
panels a–c). The cells at 8 days in culture, when the glyco-nano-
particles are added, typically consist of about 30% mature cells
with ﬂat membrane sheets (resembling Fig. 2a–c) and are almost
completely GalC and MBP-positive, even when less mature with
only thin processes instead of membrane sheets. However, after
treatment with glyco-nanoparticles, more cells appeared less ma-
ture than the control cells, with many narrow processes rather
than ﬂat membrane sheets. In most of these less mature GalC+
cells, MBP staining was very low or absent, in contrast to un-
treated OLs. An example of this type of cell is shown in Fig. 2g–
i. These effects, particularly the almost complete absence of
MBP staining, were not commonly observed after liposome treat-
ment. Since MBP appears relatively late in OL differentiation [18],
its loss in the treated cells suggests that dedifferentiation may
have occurred. The effects of the Gal, SGal, Gal/SGal and control
nanoparticles on GalC clustering, cell morphology, and MBP stain-
ing were quantiﬁed by counting the percentage of affected cells
as described [26]. The Gal, SGal, and Gal/SGal nanoparticles all in-
creased the percentage of cells with clustered or redistributed
GalC, decreased the percentage of mature GalC+ cells, and de-
creased the percentage of the GalC+ cells which were also MBP-
positive (Fig. 3).
The Gal, SGal, or mixed Gal/SGal-nanoparticles had signiﬁcantly
more effect than Glu-, Man-, or unglycosylated-nanoparticles
(Fig. 3). The nanoparticles bearing both Gal and SGal had a signif-
icantly greater effect on GalC redistribution than those with only
Gal or SGal. Untreated mature cells have a complex cytoskeletal
network with major veins and a lacy network of microtubules
(49). The Gal/SGal nanoparticles also caused loss of the microtubu-
lar network (not shown) as found for GalC/SGC-containing lipo-
somes [25–27].
To determine if the receptor(s) in OLs for the glyco-nanoparti-
cles were GalC/SGC, Fab fragments of anti-GalC IgG Ab (Chem-
icon) were prepared using a Pierce kit. The binding of the anti-
GalC Fab fragments to OLs was conﬁrmed using a ﬂuorescent
anti-rabbit IgG F(ab0)2 speciﬁc Ab (JacksonImmuno Research
Lab). For blocking of the glyco-nanoparticles, Fab fragments were
added to OLs at a ﬁnal concentration of 2 lg/well 2 h before
addition of the glyco-nanoparticles, the cells were washed, and
the glyco-nanoparticles were added. The Fab fragments under
these conditions had no effect on the OLs after a further over-
night incubation and prevented the effect of the Gal/SGal-nano-
particles on GalC and MBP distribution and OL morphology (not
shown).
These results show that the effect of the GalC/SGC-containing
liposomes on cultured OLs is not due to uptake or transfer of lipids
between the cells and the liposomes. Moreover, a lipidic form of
the sugar is not necessary for the effect; rather a multivalent form
of the sugar, as on the surface of liposomes, or bound to a polymer
or nanoparticle, is sufﬁcient. Finally, the effects are speciﬁc for Gal
and SGal.
Interactions between single sugar molecules are disrupted by
water, but the interactions between polymeric multivalent glyco-
conjugates or membrane lipid domains, that present a multivalent
array of carbohydrate head groups, are stronger and persist in
water. Furthermore, the water at the membrane surface is more or-
dered than bulk water and less likely to hydrate the carbohydrate
groups [30]. The forces between multivalent glycoconjugates can
be measured by atomic force microscopy, surface plasmon reso-
nance and other techniques and can be strong enough to cause
speciﬁc adhesion of sponge cells into a multicellular organism (re-
viewed in [1,25]).
Fig. 2. Confocal microscope images of OLs ﬁxed with 4% paraformaldehyde for 10 min at room temperature and stained externally with monoclonal anti-GalC Ab (O1) (from
Neuromics) (b, e, and h); then permeabilized with 0.05% saponin and stained internally with anti-MBP Ab (to peptide 82–87, from AbD Serotec) (a, d, and g). Merge is shown
in (c, f, and i) (MBP, red; GalC, green). Untreated oligodendrocytes (OLs) (a–c); OLs treated overnight with 2 lg/ml Gal-nanoparticles (d–i). Panels (d–f) show MBP and GalC
redistribution/clustering in a more mature cell and is typical of that caused by GalC/SGC-containing liposomes. Panels (g–i) represent a cell which looks less mature and has
lost most of its MBP; this occurs frequently after nanoparticle treatment but is much less frequent with liposome treatment. OLs were cultured, treated with nanoparticles,
stained with primary Abs and appropriate ﬂuorescent second Abs, and examined by confocal microscopy as described [26]. Bar = 20 lm.
1774 J.M. Boggs et al. / FEBS Letters 584 (2010) 1771–17785. Receptors in OLs which interact with multivalent Gal/SGal by
trans interactions
The receptor(s) in the OL membrane which interact with the
multivalent Gal/SGal presented by liposomes or polymers could
be protein(s), but are likely to be GalC and SGC for the following
reasons: (i) GalC and SGC can bind to each other by trans interac-
tions across apposed surfaces [20,24,25]; (ii) the effects of multiva-
lent presentations of Gal/SGal on OLs resemble the effects of anti-
GalC/SGC Abs reported by Dyer and Benjamins [16,17] in many re-
spects; (iii) Fab fragments of anti-GalC IgG Ab, which had no effects
on OLs themselves, prevented the effects of the Gal/SGal-nanopar-
ticles on GalC and MBP distribution and OL morphology (not
shown); (iv) the multivalent Gal/SGal had no effect on the cyto-
skeleton of astrocytes that were also present in the culture, and
that lack these two GSLs, indicating a speciﬁc effect on GalC/SGC-
containing OLs [25,27]; (v) inhibition of GSL synthesis by treat-
ment of OLs with fumonisin B1 prevented the effect of liposomal
GalC/SGC on MBP redistribution in the GalC/SGC-negative OLs[1,28]. These results support our suggestion that the natural li-
gand(s) for GalC and SGC in OLs that are mimicked by anti-GalC/
SGC Abs or multivalent Gal/SGal are, or include, GalC and SGC in
apposed OL/myelin membranes.
6. GalC/SGC signaling releases cytoskeletal restriction of
membrane domains
Jasplakinolide, a reagent which stabilizes actin ﬁlaments, inhib-
ited liposome-induced redistribution of all the membrane constit-
uents which were clustered in its absence, including GalC on the
extracellular surface [26]. It also prevented depolymerization of
the microtubules. This result indicates that depolymerization of
the actin ﬁlaments is required both for redistribution of the mem-
brane constituents and for depolymerization of the microtubules.
Thus, it is an early event in the transmembrane signaling mediated
by multivalent Gal/SGal. The fact that it also prevented clustering
of GalC on the extracellular surface suggests that GalC is somehow
linked to elements on the cytoplasmic side and/or that it is not
Fig. 3. Effect of glyco-nanoparticles (2 lg/ml) on OLs after overnight incubation.
Percentages of cells with clustered GalC, mature cells, and MBP+ cells are shown
after no treatment (black) or after treatment with particles bearing Gal (red), SGal
(green), Gal/SGal (yellow), Glu (dark blue), Man (magenta), unglycosylated
(turquoise). Data represent means ± S.D. of 3–6 experiments. The percentages of
affected cells (clustered GalC, mature cells, and MBP+ (of GalC+ cells) cells) after
treatment with Gal/SGal-nanoparticles are signiﬁcantly different from those treated
with unglycosylated-nanoparticles, P < 0.001. The percentage of cells with clustered
GalC after treatment with Gal/SGal-nanoparticles is signiﬁcantly different from that
after treatment with SGal- or Gal-nanoparticles (P 6 0.05). Statistical signiﬁcance
determined by Student’s t-test.
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domains/rafts that redistribute and coalesce (Fig. 4).
Since actin depolymerization is an early event following inter-
action of multivalent Gal/SGal with the OL membrane, this interac-
tion must ﬁrst cause transmission of a signal across the membrane
which affects actin. This initial signal may be Ca2+ entry, as found
when anti-GalC Ab was added to OLs [16,17], or a mechanical sig-
nal. Depolymerization of the cytoskeleton then allows redistribu-
tion and coalescence of microdomains enriched in GalC, MBP,
and the other membrane constituents examined. This sequence
of events suggests that the cytoskeleton restricts lateral diffusion
of these membrane constituents, either by binding to them or by
binding to other transmembrane proteins. This is consistent with
the membrane skeleton fence or picket fence model [31] and with
studies indicating that lipids and transmembrane proteins undergo
hop diffusion in compartmentalized membrane domains of 50–
200 nm [32,33]. Upon depolymerization of the cytoskeleton, these
domains are able to redistribute and coalesce into large clusters
(Fig. 4). Non-covalent crosslinking or patching of the small mem-
brane domains/rafts restrained within these compartments by
the multivalent Gal/SGal may facilitate this redistribution.
7. Role of MBP in transmission of GalC/SGC-mediated signal
MBP on the cytosolic side may play an important role in trans-
mission of the GalC/SGC-mediated signal to the cytoskeleton. Ear-
lier studies by Dyer et al. showed that anti-GalC Ab did not cause
effects in OLs from the shiverer mutant mouse, which lacks MBP
[19]. Suppression of MBP synthesis in normal rat OLs using MBP
siRNA signiﬁcantly inhibited the effect of GalC/SGC-containing lip-
osomes on GalC redistribution in the MBP-negative OLs [28] and on
the cytoskeleton (Boggs and Gao, unpublished). MBP binds to and
assembles actin ﬁlaments and microtubules and binds actin and
microtubules to a lipid bilayer, and it may tether the cytoskeletonto the plasma membrane in OLs [34,35]. Low density DIGs isolated
from OLs and myelin also contained actin and tubulin [11,36,37] in
addition to MBP, indicating that rafts may be linked to the mem-
brane skeleton in OLs via MBP, in addition to other proteins
(Fig. 4). These results also suggest that MBP may be linked to cyto-
skeletal proteins even in myelin. DIGs frommyelin also contain the
radial component, which is made up of tight junctions that may
control the ionic content of the extracellular space in myelin [1,38].8. Role of glycosynapses in OLs or myelin
We have suggested that GalC/SGC-enriched microdomains in
the OL/myelin membrane interact with each other in glycosynaps-
es between apposed membranes of OL processes in contact with
each other, or between the extracellular surfaces of compact mye-
lin (Fig. 1). If OLs are in contact at high densities, or if OL processes
contact an already myelinated axon, this contact might cause pro-
cess retraction involving disruption of the cytoskeleton (Fig. 1A). A
signal applied to SGC via a glycosynapse might be expected to in-
hibit differentiation and process extension [4] as observed with
anti-SGC Ab [5,6,18]. The increased number and decreased apopto-
sis of OLs in the CST-null mouse [7] may be due to a failure of con-
tact inhibition normally mediated by GalC/SGC interactions.
Dynamic regulation of the cytoskeleton is necessary for various
stages of myelination [1,39]. When mature myelinating OLs ini-
tially ensheath axons, the ﬁrst few layers of membrane around
the axon contain cytosol [40]. Disruption of the cytoskeleton in
these layers is necessary for the cytoplasmic surfaces to adhere
and create compact myelin. GalC–SGC interactions could occur as
the membrane sheets wrap around the nerve axon allowing GSLs
in apposed surfaces to come into contact at least transiently and/
or in localized domains and confer a signal for compaction
(Fig. 1B). In CST-null mice, the processes which myelinate are
thicker and retain more cytoplasm than in wild-type mice [7], per-
haps due to retention of the cytoskeleton in the absence of GalC/
Sulf interactions. Formation of compact myelin requires close
apposition between each pair of facing extracellular surfaces, and
between each pair of facing cytoplasmic surfaces, which may be
promoted by protein and GSL clustering. Fitzner et al. [14] have
shown that co-culture of OLs with neurons induced GalC ordering
in OL membranes, which was probably due to GalC clustering, and
increased MBP distribution into DIGs. Thus, a neuronal signal
inducing OL processes to ensheath the axon could be followed by
GalC/SGC contact between the apposed membranes, depolymer-
ization of the cytoskeleton, and protein and GSL clustering, leading
to elimination of cytosol and adhesion of the cytosolic surfaces.
Signaling resulting from trans GalC–SGC interactions may also
occur in the mature myelin sheath (Fig. 1C). Although X-ray dif-
fraction and electron microscopy indicate that the static separation
of the extracellular surfaces of compact myelin is too great for the
carbohydrate head groups of these GSLs to be in contact [41], we
have argued that they may come into transient contact under some
conditions that cause protein clustering, such as increased extra-
cellular Ca2+ concentration [1,25]. Communication between the
myelin sheath and the axon may regulate both axonal and myelin
function and provide trophic support to the axon [42]. This trophic
support by the myelin sheath may compensate for its shielding of
the axon from extracellular metabolic support. It may be necessary
to prevent neurodegeneration, since neurodegeneration occurs in
mutant mice in which one of several myelin proteins, such as
PLP, 20,30-cyclic nucleotide 30-phosphodiesterase (CNP), or mye-
lin-associated glycoprotein (MAG), is eliminated, even though an
apparently normal myelin sheath is formed [43]. The myelin
sheath has recently been shown to produce ATP through genera-
tion of a proton gradient across the lamellae, and has been postu-
Fig. 4. Effects of multivalent Gal/SGal on OL membrane sheets. GalC and SGC-enriched membrane domains (rafts) in OL membrane sheets also contain MBP, a peripheral
membrane protein on the cytoplasmic side, and are linked to the membrane skeleton (made up of linked blue spheres) via MBP [34,35], transmembrane proteins and/or other
membrane-actin binding proteins. Some transmembrane proteins (blue oblongs) bound to the membrane skeleton serve as picket fences, according to the hypothesis of
Kusumi and co-workers [31–33], that restrict lateral diffusion of both lipids and proteins in the membrane domains. Upper panel – binding of multivalent Gal/SGal (GalC/
SGC-containing liposomes or glyco-nanoparticles conjugated to Gal and SGal, depicted by large purple spheres bearing Gal (lavender hexagon) and SGal (lavender hexagon
with small yellow sphere)), crosslinks GalC and SGC molecules in the membrane domains, and triggers an initial signal, possibly Ca2+ entry, which causes dissociation of actin
ﬁlaments and microtubules and their depolymerization. Lower panel – loss of the membrane skeleton permits lateral diffusion of the membrane domains so that they
coalesce into larger clusters. The membrane domains may contain a number of other transmembrane proteins such as PLP and MOG, and signaling proteins such as MAPK
(not shown), since they redistribute together with GalC, SGC, and MBP [26]. MBP on the cytoplasmic side may be linked to GalC/SGC on the extracellular side via one of these
transmembrane proteins, since MBP is inﬂuenced by the GalC/SGC crosslinking and is necessary for transmission of the extracellular signal to the cytoskeleton [19,1]. The
head groups of the lipids are depicted as GalC (green) SGC (purple), gangliosides (yellow), phospholipids (PL) (pink); cholesterol (red rod). Similar interaction between GalC/
SGC-enriched domains in apposed OL or myelin membranes is postulated to create a glycosynapse and have a similar signaling effect.
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the axons [44]. Participation of transient GalC and SGC interactions
between the apposed extracellular surfaces of mature myelin
might allow transmission of signals throughout the myelin sheath
regulating such metabolic activity, and thus facilitate myelin–axo-
nal communication and trophic support of the axon. In support of
this conclusion, deletion of SGC in the CST-null mouse decreasedthe caliber and shape of the axon with age [3], suggesting that
the lack of SGC decreased signaling from myelin to the axon.
9. Altered GalC/SGC interactions in demyelinating disease
Interestingly, IgM Ab to GalC or SGC, produced by hybridoma
cells implanted in the spinal cord in vivo, or in an in vitro myelinat-
J.M. Boggs et al. / FEBS Letters 584 (2010) 1771–1778 1777ing culture, resulted in formation of myelin with a large space be-
tween the extracellular surfaces and paranodal loops, without tight
junctions between them [45]. Thus the multivalent IgM Ab re-
placed normal interactions between the extracellular surfaces. A
similar IgG Ab, however, which would not be able to link the ap-
posed extracellular surfaces, prevented myelin formation. These
results indicate that some type of interaction between the extracel-
lular surfaces is necessary for myelin to form and function, but that
the spacing can be wider than normal as long as the surfaces are
linked via a molecular interaction. IgM Abs produced in peripheral
neuropathies and in multiple sclerosis, including anti-GalC and
anti-SGC Abs [46], cause formation of myelin with similar wide-
spaced lamellae [47]. The Ab linking of apposed myelin lamellae
could mediate signals that could have both positive and negative
effects on OLs and myelination. Anti-GalC and anti-SGC Abs pro-
duced in these diseases may also have signaling effects on OLs in
vivo, as found in the in vitro studies. Indeed, antibodies to these
and other myelin constituents have been found to ameliorate
disease in animal models for demyelinating diseases [48]. Simi-
larly, multivalent arrays of Gal and SGal, such as the Gal/SGal-
nanoparticles used here, could have potential beneﬁcial effects
on myelination or myelin function; this possibility warrants
further investigation.
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